Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67326 - 67350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	TIPARP	25976	upregulated	rosiglitazone results in increased expression of TIPARP mRNA	3q25.31	A20427
Rosiglitazone	Approved Investigational	TKFC	26007	downregulated	rosiglitazone results in decreased expression of TKFC mRNA	11q12.2	A22609
Rosiglitazone	Approved Investigational	TM6SF2	53345	downregulated	rosiglitazone results in decreased expression of TM6SF2 mRNA	19p13.11	A22609
Rosiglitazone	Approved Investigational	TMEM14A	28978	downregulated	rosiglitazone results in decreased expression of TMEM14A mRNA	6p12.2	A10216
Rosiglitazone	Approved Investigational	TMEM171	134285	upregulated	rosiglitazone results in increased expression of TMEM171 mRNA	5q13.2	A22609
Rosiglitazone	Approved Investigational	TMEM41A	90407	downregulated	rosiglitazone results in decreased expression of TMEM41A mRNA	3q27.2	A22609
Rosiglitazone	Approved Investigational	TMEM86B	255043	downregulated	rosiglitazone results in decreased expression of TMEM86B mRNA	19q13.42	A22609
Rosiglitazone	Approved Investigational	TMPRSS6	164656	downregulated	rosiglitazone results in decreased expression of TMPRSS6 mRNA	22q12.3	A22609
Rosiglitazone	Approved Investigational	TNFRSF10B	8795	upregulated	rosiglitazone results in increased expression of TNFRSF10B mRNA	8p21.3	A24147
Rosiglitazone	Approved Investigational	TNFRSF21	27242	upregulated	rosiglitazone results in increased expression of TNFRSF21 mRNA	6p12.3	A22609
Rosiglitazone	Approved Investigational	TNFSF12	8742	downregulated	rosiglitazone results in decreased expression of TNFSF12 mRNA	17p13.1	A10216
Rosiglitazone	Approved Investigational	TNS1	7145	downregulated	rosiglitazone results in decreased expression of TNS1 mRNA	2q35	A10216
Rosiglitazone	Approved Investigational	TP53	7157	upregulated	rosiglitazone results in increased expression of TP53 mRNA	17p13.1	A24100
Rosiglitazone	Approved Investigational	TP53INP1	94241	downregulated	rosiglitazone results in decreased expression of TP53INP1 mRNA	8q22.1	A20427
Rosiglitazone	Approved Investigational	TP53INP2	58476	downregulated	rosiglitazone results in decreased expression of TP53INP2 mRNA	20q11.22	A22609
Rosiglitazone	Approved Investigational	TPR	7175	downregulated	rosiglitazone results in decreased expression of TPR mRNA	1q31.1	A22609
Rosiglitazone	Approved Investigational	TRIB3	57761	downregulated	rosiglitazone results in decreased expression of TRIB3 mRNA	20p13	A22609
Rosiglitazone	Approved Investigational	TROVE2	6738	downregulated	rosiglitazone results in decreased expression of TROVE2 mRNA	1q31.2	A20427
Rosiglitazone	Approved Investigational	TRPM8	79054	upregulated	rosiglitazone results in increased expression of TRPM8 mRNA	2q37.1	A22609
Rosiglitazone	Approved Investigational	TUBB2A	7280	downregulated	rosiglitazone results in decreased expression of TUBB2A mRNA	6p25.2	A22609
Rosiglitazone	Approved Investigational	UCP2	7351	upregulated	rosiglitazone results in increased expression of UCP2 mRNA	11q13	A4815 A24109 A24128 A23573
Rosiglitazone	Approved Investigational	UGT1A1	54658	upregulated	rosiglitazone results in increased expression of UGT1A1 mRNA	2q37.1	A22609
Rosiglitazone	Approved Investigational	UGT1A3	54659	upregulated	rosiglitazone results in increased expression of UGT1A3 mRNA	2q37.1	A22609
Rosiglitazone	Approved Investigational	USP3	9960	upregulated	rosiglitazone results in increased expression of USP3 mRNA	15q22.3	A20427
Rosiglitazone	Approved Investigational	VEGFB	7423	upregulated	rosiglitazone results in increased expression of VEGFB mRNA	11q13.1	A20427

Displaying entries 67326 - 67350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability